Finance

Lists
Why is LTRN up 2,35%?
Dive Deeper
LTRN:NASDAQ
Lantern Pharma Inc
USD 0,66
+2,35%
(+0,015) 1D
USD 0,70
+6,60% (+0,043)
After hours
Closed: 20 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LTRN...
Open
USD 0,63
High
USD 0,75
Low
USD 0,60
Mkt. cap
9,82 m
Avg. vol.
276,74 k
Volume
1,88 m
52-wk high
USD 4,34
52-wk low
USD 0,60
EPS
-USD 1,61
Beta
2,33
Shares outstanding
14,94 m
No. of employees
16
Open
USD 0,63
High
USD 0,75
Low
USD 0,60
Mkt. cap
9,82 m
Avg. vol.
276,74 k
Volume
1,88 m
52-wk high
USD 4,34
52-wk low
USD 0,60
EPS
-USD 1,61
Beta
2,33
Shares outstanding
14,94 m
No. of employees
16
News stories
From web sources and news partners
About Lantern Pharma Inc
CEO-
Employees16
Founded2013
HeadquartersDallas, Texas, Verenigde State van Amerika
Sector-
Websitelanternpharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
Chad Messer
Lake Street
Buy
Maintained
USD 25,00
+3 708,7%
05/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,44 m
2,74 m
1,72 m
1,79 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,91 m
1,46 m
1,68 m
1,72 m
Operating expense
4,35 m
4,20 m
3,41 m
3,51 m
Total operating expenses
4,35 m
4,20 m
3,41 m
3,51 m
Operating income
-4,35 m
-4,20 m
-3,41 m
-3,51 m
Other non operating income
71,46 k
63,47 k
93,37 k
-3,59 m
EBT including unusual items
-4,18 m
-4,07 m
-3,33 m
-7,07 m
EBT excluding unusual items
-4,18 m
-4,07 m
-3,27 m
-7,07 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,18 m
-4,07 m
-3,33 m
-7,07 m
Net profit margin
-
-
-
-
Earnings per share
-0,39
-0,36
-0,30
-0,28
Interest and investment income
100,92 k
72,48 k
42,16 k
30,08 k
Interest expense
-
-
-
-
Net interest expenses
100,92 k
72,48 k
42,16 k
30,08 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,35 m
-4,20 m
-3,40 m
-3,50 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme